These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cefepime-Induced Non-Convulsive Status Epilepticus in a Patient with Normal Renal Function. Park HM; Noh Y; Yang JW; Shin DH; Lee YB J Epilepsy Res; 2016 Dec; 6(2):97-99. PubMed ID: 28101482 [TBL] [Abstract][Full Text] [Related]
44. [Non-convulsive status epilepticus secondary to adjusted cefepime doses in patients with chronic renal failure]. Saurina A; Vera M; Pou M; López Pedret J; Darnell A; Campistol JM; Cases A Nefrologia; 2000; 20(6):554-8. PubMed ID: 11217651 [TBL] [Abstract][Full Text] [Related]
45. [Cefepime-associated encephalopathy in a patient with septic shock and renal failure]. Sánchez-Bailén MJ; Navarro Ciruelos N; Rovira García-Marrón R; Anglès Coll R Rev Clin Esp; 2004 Sep; 204(9):501-2. PubMed ID: 15388030 [No Abstract] [Full Text] [Related]
50. Cefepime-Induced Depressive Disorder in a Patient With End-Stage Renal Disease. Lo YF; Chien CW; Tai YM; Kuo SC; Lin SH; Tzeng NS Am J Ther; 2022 Jan-Feb 01; 29(1):e111-e113. PubMed ID: 34994352 [No Abstract] [Full Text] [Related]
51. Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature. Lindsay H; Gruner S; Brackett J J Pediatric Infect Dis Soc; 2017 Jun; 6(2):199-201. PubMed ID: 27147713 [TBL] [Abstract][Full Text] [Related]
58. The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study. Fujita M; Matsumoto T; Inoue Y; Wataya H; Takayama K; Ishida M; Ebi N; Kishimoto J; Ichinose Y; J Infect Chemother; 2016 Apr; 22(4):235-9. PubMed ID: 26867793 [TBL] [Abstract][Full Text] [Related]